Comparative in vitro activity of silver sulfadiazine, alone and in combination with cerium nitrate, against staphylococci and gram-negative bacteria

Journal of Chemotherapy
P MaroneE Carretto

Abstract

Silver sulfadiazine (SSD), a topical antimicrobial agent, has been widely used for the prophylaxis and treatment of burn infections during the past 30 years. We determined the antimicrobial activity of SSD, alone and in combination with cerium nitrate (CN), gentamicin and amikacin against 130 recent clinical isolates, including multiresistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa. The overall activity of SSD was good against all the tested strains and it was particularly high against MRSA (MIC90 100 microg/ml). CN showed no inhibitory effect, even up to 800 microg/ml, on bacterial strains tested. The combination of SSD and CN was as active as SSD alone. In conclusion, SSD has a broad spectrum of activity at concentrations lower than those commonly used in clinical preparations. All strains were inhibited by less then one-fiftieth of the SSD "in use" concentration (10 mg/ml). Our data confirm the efficacy of this topical agent in the prevention and treatment of infections in burns or other surgical wounds and suggest its possible use in clearing staphylococcal carriage as an alternative to mupirocin.

References

Dec 1, 1992·Burns : Journal of the International Society for Burn Injuries·W BoeckxA Schmitz
Mar 1, 1992·The Journal of Burn Care & Rehabilitation·E C SmootJ E Barenfanger
May 1, 1973·Antimicrobial Agents and Chemotherapy·J E CowardH S Rosenkranz
Mar 1, 1982·Burns, Including Thermal Injury·I A Holder
Nov 1, 1993·Chemotherapy·J M Hamilton-MillerC Smith

❮ Previous
Next ❯

Citations

Apr 9, 2001·Clinical Microbiology Reviews·P G BowlerD G Armstrong
Jun 28, 2011·Annals of Clinical Microbiology and Antimicrobials·Fabien AujoulatEstelle Jumas-Bilak
Jan 22, 2014·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·G DaeschleinM Jünger
May 5, 2005·Journal of the American Animal Hospital Association·J Scott Weese
Mar 19, 2005·Burns : Journal of the International Society for Burn Injuries·J P Garner, P S J Heppell
Jun 16, 2005·Burns : Journal of the International Society for Burn Injuries·J P Garner, P S J Heppell
Jul 24, 2008·Burns : Journal of the International Society for Burn Injuries·Martin AllgöwerBrian G Sparkes
Oct 28, 2003·The Journal of Dermatology·Anjum Singal, Gurvinder P Thami
Apr 6, 2004·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Ronen GlesingerLior Rosenberg
Mar 28, 2007·International Journal of Surgery·Seyed V HosseiniHooman Yarmohammadi
Apr 6, 2004·The Veterinary Clinics of North America. Small Animal Practice·Daniel O Morris
Jan 1, 2013·Journal of Functional Biomaterials·Deepen PaulPankaj Vadgama
Jul 25, 2008·The Journal of Craniofacial Surgery·Priti P PatelSamuel T Rhee
Sep 4, 2004·Journal of the American Veterinary Medical Association·Brian S PalmeiroFrances S Shofer
Jun 29, 2006·Operative Dentistry·Alex José Souza SantosJosé Roberto Lovadino
Apr 8, 2003·Journal of Wound Care·A B G LansdownP O'Sullivan
Jun 7, 2003·Journal of Oral Rehabilitation·S DebB Millar
Dec 7, 2019·Journal of Burn Care & Research : Official Publication of the American Burn Association·Li-Wu QianKai P Leung
Sep 21, 2010·Journal of Wound Care·C Signe-PicardL Téot
Aug 1, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·A MastrolorenzoC T Supuran
Jan 4, 2019·Dermatology : International Journal for Clinical and Investigative Dermatology·Amandine DarresStanislas Faguer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.